These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20580483)

  • 1. Prostate cancer prevention trial and European randomized study of screening for prostate cancer risk calculators: a performance comparison in a contemporary screened cohort.
    Cavadas V; Osório L; Sabell F; Teves F; Branco F; Silva-Ramos M
    Eur Urol; 2010 Oct; 58(4):551-8. PubMed ID: 20580483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy.
    Nguyen CT; Yu C; Moussa A; Kattan MW; Jones JS
    J Urol; 2010 Feb; 183(2):529-33. PubMed ID: 20006887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort.
    Trottier G; Roobol MJ; Lawrentschuk N; Boström PJ; Fernandes KA; Finelli A; Chadwick K; Evans A; van der Kwast TH; Toi A; Zlotta AR; Fleshner NE
    BJU Int; 2011 Oct; 108(8 Pt 2):E237-44. PubMed ID: 21507190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer risk calculators indicating a positive prostate biopsy: a comparison.
    van den Bergh RC; Roobol MJ; Wolters T; van Leeuwen PJ; Schröder FH
    BJU Int; 2008 Nov; 102(9):1068-73. PubMed ID: 18715246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for prostate cancer: have we resolved the controversy?
    Zhu X; Roobol MJ; Schröder FH
    Curr Opin Support Palliat Care; 2010 Sep; 4(3):121-6. PubMed ID: 20489646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial.
    Otto SJ; Schröder FH; de Koning HJ
    J Clin Oncol; 2006 Sep; 24(25):4184-9. PubMed ID: 16943535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population.
    Parekh DJ; Ankerst DP; Higgins BA; Hernandez J; Canby-Hagino E; Brand T; Troyer DA; Leach RJ; Thompson IM
    Urology; 2006 Dec; 68(6):1152-5. PubMed ID: 17169636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH
    Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for prostate cancer (PC)--an update on recent findings of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
    Schröder FH
    Urol Oncol; 2008; 26(5):533-41. PubMed ID: 18774469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
    Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
    J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it necessary to detect all prostate cancers in men with serum PSA levels <3.0 ng/ml? A comparison of biopsy results of PCPT and outcome-related information from ERSPC.
    Schröder FH; Bangma CH; Roobol MJ
    Eur Urol; 2008 May; 53(5):901-8. PubMed ID: 18262712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining increased future risk for prostate cancer: evidence from a population based screening cohort.
    Schröder FH; Roobol MJ; Andriole GL; Fleshner N
    J Urol; 2009 Jan; 181(1):69-74; discussion 74. PubMed ID: 19012915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?
    Otto SJ; Schröder FH; de Koning HJ
    J Med Screen; 2004; 11(2):89-92. PubMed ID: 15153324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
    Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
    Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall survival in the intervention arm of a randomized controlled screening trial for prostate cancer compared with a clinically diagnosed cohort.
    Vis AN; Roemeling S; Reedijk AM; Otto SJ; Schröder FH
    Eur Urol; 2008 Jan; 53(1):91-8. PubMed ID: 17583416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The European Randomized Study of Screening for Prostate Cancer: an update.
    Standaert B; Denis L
    Cancer; 1997 Nov; 80(9):1830-4. PubMed ID: 9351556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of developing prostate cancer in the future: overview of prognostic biomarkers.
    Fleshner NE; Lawrentschuk N
    Urology; 2009 May; 73(5 Suppl):S21-7. PubMed ID: 19375623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate-specific antigen tests and prostate cancer screening: an update for primary care physicians.
    Kell JS
    Can J Urol; 2010 Feb; 17 Suppl 1():18-25. PubMed ID: 20170597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of 54 biomarkers for biopsy-detectable prostate cancer.
    Parekh DJ; Ankerst DP; Baillargeon J; Higgins B; Platz EA; Troyer D; Hernandez J; Leach RJ; Lokshin A; Thompson IM
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1966-72. PubMed ID: 17932343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for prostate cancer.
    Brawley OW; Ankerst DP; Thompson IM
    CA Cancer J Clin; 2009; 59(4):264-73. PubMed ID: 19564245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.